The use of FDG-PET to target tumors by radiotherapy

Strahlentherapie und Onkologie

Volumn 186, Issue 9, 2010, Pages 471-481

  Lammering, Guido ^a   De Ruysscher, Dirk ^a   Van Baardwijk, Angela ^a   Baumert, Brigitta G ^a   Borger, Jacques ^a   Lutgens, Ludy ^a   Van Den Ende, Piet ^a   Öllers, Michel ^a   Lambin, Philippe ^a  

^a MAASTRO CLINIC   (Netherlands)

Author keywords

PET; Radiotherapy; Target delineation; Treatment planning

Indexed keywords

1,4,7,10 TETRAAZACYCLODODECANE 1,4,7,10 TETRAACETIC ACID OCTREOTIDE[DEXTRO PHENYL 3 TYROSINE] GA 68; ANTINEOPLASTIC AGENT; FLUORO 3' DEOXY 3' FLUOROTHYMIDINE F 18; FLUORODEOXYGLUCOSE F 18; GADOLINIUM; METHIONINE C 11; RADIOPHARMACEUTICAL AGENT; TYROSINE F 18; UNCLASSIFIED DRUG;

ANUS CARCINOMA; BRAIN TUMOR; CALIBRATION; CANCER GRADING; CANCER RADIOTHERAPY; CLINICAL PROTOCOL; CLINICAL TRIAL; COMPUTER ASSISTED RADIOTHERAPY; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; DIAGNOSTIC ACCURACY; ESOPHAGUS CARCINOMA; FRACTONATED STEREOTACTIC RADIOTHERAPY; GLIOBLASTOMA; GLIOMA; HEAD AND NECK CANCER; HODGKIN DISEASE; HUMAN; HYPOPHYSIS ADENOMA; INTERMETHOD COMPARISON; LUNG NON SMALL CELL CANCER; LUNG SMALL CELL CANCER; LYMPH NODE METASTASIS; MENINGIOMA; NERVOUS SYSTEM TUMOR; NONHODGKIN LYMPHOMA; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; POSITRON EMISSION TOMOGRAPHY; PRIMARY TUMOR; RADIATION DOSE; RECTUM CANCER; RECTUM CARCINOMA; REVIEW; STEREOTACTIC RADIOSURGERY; TREATMENT PLANNING; TUMOR VOLUME; UTERINE CERVIX CARCINOMA;

BRAIN NEOPLASMS; CARCINOMA, NON-SMALL-CELL LUNG; FLUORODEOXYGLUCOSE F18; HUMANS; LUNG NEOPLASMS; NEOPLASM STAGING; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS;

EID: 77957780175     PISSN: 01797158     EISSN: 1439099X     Source Type: Journal    
DOI: 10.1007/s00066-010-2150-1     Document Type: Review

References (82)

1. H. Abdel-Nabi R.J. Doerr D.M. Lamonica 1998 Staging of primary colorectal carcinomas with fluorine-18 fluorodeoxyglucose whole-body PET: correlation with histopathologic and CT findings Radiology 206 755 60 1:STN:280: DyaK1c7lsFKjsw%3D%3D 9494497
2. H.J. Aerts G. Bosmans A.A. van Baardwijk 2008 Stability of (18)F-deoxyglucose uptake locations within tumor during radiotherapy for NSCLC: a prospective study Int J Radiat Oncol Biol Phys 71 1402 7 1:CAS:528: DC%2BD1cXoslWqsLs%3D 18234432
3. H.J. Aerts A.A. van Baardwijk S.F. Petit 2009 Identification of residual metabolic-active areas within individual NSCLC tumours using a pre-radiotherapy (18)fluorodeoxyglucose-PET-CT scan Radiother Oncol 91 386 92 10.1016/j.radonc.2009.03.006 19329207
4. C. Anderson M. Koshy C. Staley 2007 PET-CT fusion in radiation management of patients with anorectal tumors Int J Radiat Oncol Biol Phys 69 155 62 17707268
5. S.T. Astner M. Dobrei-Ciuchendea M. Essler 2008 Effect of 11C-methionine-positron emission tomography on gross tumor volume delineation in stereotactic radiotherapy of skull base meningiomas Int J Radiat Oncol Biol Phys 72 1161 7 18440729
6. J.S. Belderbos W.D. Heemsbergen K. De Jaeger 2006 Final results of a phase I/II dose escalation trial in non-small-cell lung cancer using three-dimensional conformal radiotherapy Int J Radiat Oncol Biol Phys 66 126 34 16904518
7. T. Belhocine A. Thille V. Fridman 2002 Contribution of whole-body 18FDG PET imaging in the management of cervical cancer Gynecol Oncol 87 90 7 10.1006/gyno.2002.6769 12468348 (Pubitemid 36027107)
8. M. Bergström C. Muhr P.O. Lundberg B. Långström 1991 PET as a tool in the clinical evaluation of pituitary adenomas J Nucl Med 32 610 5 2013801
9. R. Boellaard W.J. Oyen C.J. Hoekstra 2008 The Netherlands protocol for standardisation and quantification of FDG whole body PET studies in multi-centre trials Eur J Nucl Med Mol Imaging 35 2320 33 10.1007/s00259-008-0874-2 18704407
10. C. Capirci D. Rubello F. Pasini 2009 The role of dual-time combined 18-fluorodeoxyglucose positron emission tomography and computed tomography in the staging and restaging workup of locally advanced rectal cancer, treated with preoperative chemoradiation therapy and radical surgery Int J Radiat Oncol Biol Phys 74 1461 9 19419820
11. H.J. Choi J.W. Roh S.S. Seo 2006 Comparison of the accuracy of magnetic resonance imaging and positron emission tomography/computed tomography in the presurgical detection of lymph node metastases in patients with uterine cervical carcinoma: a prospective study Cancer 106 914 22 10.1002/cncr.21641 16411226 (Pubitemid 43238460)
12. I.F. Ciernik E. Dizendorf B.G. Baumert 2003 Radiation treatment planning with an integrated positron emission and computer tomography (PET/CT): a feasibility study Int J Radiat Oncol Biol Phys 57 853 63 14529793
13. J.F. Daisne T. Duprez B. Weynand 2004 Tumor volume in pharyngolaryngeal squamous cell carcinoma: comparison at CT, MR imaging, and FDG PET and validation with surgical specimen Radiology 233 93 100 10.1148/radiol.2331030660 15317953 (Pubitemid 39280962)
14. D. De Ruysscher S. Wanders A. Minken 2005 Effects of radiotherapy planning with a dedicated combined PET-CT-simulator of patients with non-small cell lung cancer on dose limiting normal tissues and radiation dose-escalation: results of a prospective study Radiother Oncol 77 5 10 10.1016/j.radonc.2005.06. 014 16019093 (Pubitemid 41503382)
15. D. De Ruysscher S. Wanders E. van Haren 2005 Selective mediastinal node irradiation on basis of the FDG-PET scan in patients with non-small cell lung cancer: a prospective clinical study Int J Radiat Oncol Biol Phys 62 988 94 15989999
16. C. Divgi 2005 Imaging: staging and evaluation of lymphoma using nuclear medicine Semin Oncol 32 Suppl1 S11 8 10.1053/j.seminoncol.2005.01.009 15786021 (Pubitemid 40409899)
17. H.T. Eich R.P. Müller R. Engenhart-Cabillic 2008 German Hodgkin Study Group. Involved-node radiotherapy in early-stage Hodgkin's lymphoma. Definition and guidelines of the German Hodgkin Study Group (GHSG) Strahlenther Onkol 184 406 10 10.1007/s00066-008-1882-7 18956517
18. P. Flamen A. Lerut E. Van Cutsem 2000 Utility of positron emission tomography for the staging of patients with potentially operable esophageal carcinoma J Clin Oncol 18 3202 10 1:STN:280:DC%2BD3cvotlentw%3D%3D 10986052
19. P. Flamen S. Stroobants E. Van Cutsem 1999 Additional value of whole-body positron emission tomography with fluorine-18-2-fluoro-deoxy-D-glucose in recurrent colorectal cancer J Clin Oncol 17 894 901 1:STN:280: DyaK1M7mvVyguw%3D%3D 10071281
20. F.W. Floeth M. Sabel G. Stoffels 2007 Prognostic value of O-(2-1-F-fluoroethyl)-L-tyrosine PET and MRI in low-grade glioma J Nucl Med 48 519 27 1:CAS:528:DC%2BD2sXhtVert7nM 10.2967/jnumed.106.037895 17401087 (Pubitemid 47571405)
21. T. Girinsky M. Ghalibafian G. Bonniaud 2007 Is FDG-PET scan in patients with early stage Hodgkin lymphoma of any value in the implementation of the involved-node radiotherapy concept and dose painting? Radiother Oncol 85 178 86 10.1016/j.radonc.2007.07.003 17719110 (Pubitemid 350160993)
22. T. Girinsky R. van der Maazen L. Specht 2006 Involved-node radiotherapy (INRT) in patients with early Hodgkin lymphoma: concepts and guidelines Radiother Oncol 79 270 7 10.1016/j.radonc.2006.05.015 16797755 (Pubitemid 44109907)
23. A. Grgic U. Nestle A. Schaefer-Schuler 2009 FDG-PET-based radiotherapy planning in lung cancer: optimum breathing protocol and patient positioning - an intraindividual comparison Int J Radiat Oncol Biol Phys 73 103 11 18632217
24. M.W. Gross W.A. Weber H.J. Feldmann 1998 The value of F-18-fluorodeoxyglucose PET for the 3-D radiation treatment planning of malignant gliomas Int J Radiat Oncol Biol Phys 41 989 95 1:CAS:528: DyaK1cXlslWisL4%3D 9719107
25. A.L. Grosu M. Piert M. Molls 2005 Experience of PET for target localisation in radiation oncology Br J Radiol Suppl 28 8 32
26. A.L. Grosu W.A. Weber S.T. Astner 2006 11C-methionine PET improves the target volume delineation of meningiomas treated with stereotactic fractionated radiotherapy Int J Radiat Oncol Biol Phys 66 339 44 1:CAS:528: DC%2BD28Xptlyqs7k%3D 16765533
27. A.L. Grosu W.A. Weber M. Franz 2005 Reirradiation of recurrent high-grade gliomas using amino acid PET (SPECT)/CT/MRI image fusion to determine gross tumor volume for stereotactic fractionated radiotherapy Int J Radiat Oncol Biol Phys 63 511 9 1:CAS:528:DC%2BD2MXhtVWnsLrM 16168843
28. P.A. Heeren P.L. Jager F. Bongaerts 2004 Detection of distant metastases in esophageal cancer with (18)F-FDG PET J Nucl Med 45 980 7 15181133
29. R.J. Hicks V. Kalff M.P. MacManus 2001 18F-FDG PET provides high-impact and powerful prognostic stratification in staging newly diagnosed non-small cell lung cancer J Nucl Med 42 1596 604 1:STN:280:DC%2BD3MnksValsQ%3D%3D 11696627
30. A.H. Jacobs A. Thomas L.W. Kracht 2005 18F-fluoro-L-thymidine and 11C-methylmethionine as markers of increased transport and proliferation in brain tumors J Nucl Med 46 1948 58 1:CAS:528:DC%2BD28XivVSktA%3D%3D 16330557
31. M.H. Janssen H.J. Aerts M.C. Öllers 2009 Tumor delineation based on time-activity curve differences assessed with dynamic fluorodeoxyglucose positron emission tomography-computed tomography in rectal cancer patients Int J Radiat Oncol Biol Phys 73 456 65 18556143
32. M.H. Janssen M.C. Ollers R.G. Riedl 2010 Accurate prediction of pathological rectal tumor response after two weeks of preoperative radiochemotherapy using (18)F-fluorodeoxyglucose-positron emission tomography-computed tomography imaging Int J Radiat Oncol Biol Phys 77 392 9 19646825
33. M.H. Janssen M.C. Ollers R.G. Stiphout 2010 Blood glucose level normalization and accurate timing improves the accuracy of PET-based treatment response predictions in rectal cancer Radiother Oncol 95 203 8 1:CAS:528:DC%2BC3cXltFOiuro%3D 10.1016/j.radonc.2010.01.021 20176406
34. M.H. Janssen M.C. Ollers R.G. van Stiphout 2010 Evaluation of early metabolic responses in rectal cancer during combined radiochemotherapy or radiotherapy alone: sequential FDG-PET-CT findings Radiother Oncol 94 151 5 10.1016/j.radonc.2009.12.033 20116114
35. J. Johansen S. Buus A. Loft 2008 Prospective study of 18FDG-PET in the detection and management of patients with lymph node metastases to the neck from an unknown primary tumor. Results from the DAHANCA-13 study Head Neck 30 471 8 10.1002/hed.20734 18023031 (Pubitemid 351578750)
36. I. Kantorova L. Lipska O. Belohlavek 2003 Routine 18F-FDG PET preoperative staging of colorectal cancer: comparison with conventional staging and its impact on treatment decision making J Nucl Med 44 1784 8 14602860
37. B. Kaschten A. Stevenaert B. Sadzot 1998 Preoperative evaluation of 54 gliomas by PET with fluorine-18-fluorodeoxyglucose and/or carbon-11-methionine J Nucl Med 39 778 85 1:CAS:528:DyaK1cXjsVShtbY%3D 9591574
38. C. Kobe M. Dietlein J. Franklin 2008 Positron emission tomography has a high negative predictive value for progression or early relapse for patients with residual disease after first-line chemotherapy in advanced-stage Hodgkin lymphoma Blood 112 3989 94 1:CAS:528:DC%2BD1cXhsVSmsrzF 10.1182/blood-2008-06- 155820 18757777
39. A. Konski M. Doss B. Milestone 2005 The integration of 18-fluoro-deoxy-glucose positron emission tomography and endoscopic ultrasound in the treatment-planning process for esophageal carcinoma Int J Radiat Oncol Biol Phys 61 1123 8 15752892
40. T. Leong C. Everitt K. Yuen 2006 A prospective study to evaluate the impact of FDG-PET on CT based radiotherapy treatment planning for oesophageal cancer Radiother Oncol 78 254 61 10.1016/j.radonc.2006.02.014 16545881
41. M. Levivier N. Massager D. Wikler 2004 Use of stereotactic PET images in dosimetry planning of radiosurgery for brain tumors: clinical experience and proposed classification J Nucl Med 45 1146 5 15235060
42. M. Levivier N. Massager D. Wikler S. Goldman 2004 Modern multimodal neuroimaging for radiosurgery: the example of PET scan integration Acta Neurochir (Wien) 91 1 7 1:STN:280:DC%2BD2M%2FnvVSnsw%3D%3D
43. A. Loft A.K. Berthelsen H. Roed 2007 The diagnostic value of PET/CT scanning in patients with cervical cancer: a prospective study Gynecol Oncol 106 29 34 10.1016/j.ygyno.2007.03.027 17482666 (Pubitemid 46908743)
44. M.P. MacManus R.J. Hicks J.P. Matthews 2001 High rate of detection of unsuspected distant metastases by PET in apparent stage III non-small-cell lung cancer: implications for radical radiation therapy Int J Radiat Oncol Biol Phys 50 287 93 1:STN:280:DC%2BD3M3psF2htA%3D%3D 10.1016/S0360-3016(01)01477-8 11380213 (Pubitemid 32472257)
45. K. Mah C.B. Caldwell Y.C. Ung 2002 The impact of (18)FDG-PET on target and critical organs in CT-based treatment planning of patients with poorly defined non-small-cell lung carcinoma: a prospective study Int J Radiat Oncol Biol Phys 52 339 50 11872279
46. S. Milker-Zabel A. Zabel-du Bois M. Henze 2006 Improved target volume definition for fractionated stereotactic radiotherapy in patients with intracranial meningiomas by correlation of CT, MRI, and [68Ga]-DOTATOC-PET Int J Radiat Oncol Biol Phys 65 222 7 16488553
47. K. Miwa J. Shinoda H. Yano 2004 Discrepancy between lesion distributions on methionine PET and MR images in patients with glioblastoma multiforme: insight from a PET and MR fusion image study J Neurol Neurosurg Psychiatry 75 1457 62 1:STN:280:DC%2BD2cvmslGrtw%3D%3D 10.1136/jnnp.2003.028480 15377696 (Pubitemid 39279817)
48. L. Moureau-Zabotto E. Touboul D. Lerouge 2005 Impact of CT and 18F-deoxyglucose positron emission tomography image fusion for conformal radiotherapy in esophageal carcinoma Int J Radiat Oncol Biol Phys 63 340 5 16168829
49. S.A. Nehmeh Y.E. Erdi K.E. Rosenzweig 2003 Reduction of respiratory motion artifacts in PET imaging of lung cancer by respiratory correlated dynamic PET: methodology and comparison with respiratory gated PET J Nucl Med 44 1644 8 14530480
50. U. Nestle S. Kremp A.L. Grosu 2006 Practical integration of [18F]-FDG-PET and PET-CT in the planning of radiotherapy for non-small cell lung cancer (NSCLC): the technical basis, ICRU-target volumes, problems, perspectives Radiother Oncol 81 209 25 1:CAS:528:DC%2BD28Xht1Sht7fI 10.1016/j.radonc.2006.09. 011 17064802 (Pubitemid 44780785)
51. U. Nestle A. Schaefer-Schuler S. Kremp 2007 Target volume definition for 18F-FDG PET-positive lymph nodes in radiotherapy of patients with non-small cell lung cancer Eur J Nucl Med Mol Imaging 34 453 62 10.1007/s00259-006-0252-x 17058078 (Pubitemid 46426982)
52. B. Nowak E. Di Martino S. Jänicke 1999 Diagnostic evaluation of malignant head and neck cancer by F-18-FDG PET compared to CT/MRI Nuklearmedizin 38 312 8 1:STN:280:DC%2BD3c%2Fot1GhtA%3D%3D 10615664
53. J. Nuutinen P. Sonninen P. Lehikoinen 2000 Radiotherapy treatment planning and long-term follow-up with [(11)C]methionine PET in patients with low-grade astrocytoma Int J Radiat Oncol Biol Phys 48 43 52 1:STN:280: DC%2BD3czps1aruw%3D%3D 10.1016/S0360-3016(00)00604-0 10924970 (Pubitemid 30488211)
54. T. Ogawa F. Shishido I. Kanno 1993 Cerebral glioma: evaluation with methionine PET Radiology 186 45 53 1:STN:280:DyaK3s7gtFyitQ%3D%3D 8380108
55. B. Paskeviciute T. Bölling M. Brinkmann 2009 Impact of (18)F-FDG-PET/CT on staging and irradiation of patients with locally advanced rectal cancer Strahlenther Onkol 185 260 5 10.1007/s00066-009-1962-3 19370430
56. A.C. Paulino M. Koshy R. Howell 2005 Comparison of CT and FDG-PET-defined gross tumor volume in intensity-modulated radiotherapy for head-and-neck cancer Int J Radiat Oncol Biol Phys 61 1385 92 15817341
57. F. Paulsen J. Scheiderbauer S.M. Eschmann 2006 First experiences of radiation treatment planning with PET/CT Strahlenther Onkol 182 369 75 10.1007/s00066-006-1451-x 16826354 (Pubitemid 44025003)
58. J.V. Räsänen E.I. Sihvo M.J. Knuuti 2003 Prospective analysis of accuracy of PET, CT and EUS in staging of adenocarcinoma of the esophagus and gastroesophageal cancer Ann Surg Oncol 10 954 60 10.1245/ASO.2003.12.002 14527917 (Pubitemid 40486863)
59. M. Rickhey O. Koelbl C. Eilles L. Bogner 2008 A biologically adapted dose-escalation approach, demonstrated for 18F-FET-PET in brain tumors Strahlenther Onkol 184 536 42 10.1007/s00066-008-1883-6 19016044
60. I. Rutten J.E. Cabay N. Withofs 2007 PET/CT of skull base meningiomas using 2-18F-fluoro-L-tyrosine: initial report J Nucl Med 48 720 5 1:CAS:528:DC%2BD2sXhtVertL3P 10.2967/jnumed.106.038216 17475959 (Pubitemid 47604971)
61. A. Schaefer S. Kremp D. Hellwig 2008 A contrast-oriented algorithm for FDG-PET-based delineation of tumour volumes for the radiotherapy of lung cancer: derivation from phantom measurements and validation in patient data Eur J Nucl Med Mol Imaging 35 1989 99 10.1007/s00259-008-0875-1 18661128
62. D.A. Schinagl A.L. Hoffmann W.V. Vogel 2009 Can FDG-PET assist in radiotherapy target volume definition of metastatic lymph nodes in head-and-neck cancer? Radiother Oncol 91 95 100 10.1016/j.radonc.2009.02.007 19285354
63. B.W. Schot J.M. Zijlstra W.J. Sluiter 2007 Early FDG-PET assessment in combination with clinical risk scores determines prognosis in recurring lymphoma Blood 109 486 91 1:CAS:528:DC%2BD2sXivVykurg%3D 10.1182/blood-2005-11-006957 17003382 (Pubitemid 46105942)
64. S. Senan D. De Ruysscher P. Giraud 2004 Radiotherapy Group of European Organization for Research and Treatment of Cancer. Literature-based recommendations for treatment planning and execution for high-precision radiotherapy in lung cancer Radiother Oncol 71 139 46 10.1016/j.radonc.2003.09. 007 15110446 (Pubitemid 38521181)
65. T.D. Solberg N. Agazaryan B.W. Goss 2004 A feasibility study of 18F-fluorodeoxyglucose positron emission tomography targeting and simultaneous integrated boost for intensity-modulated radiosurgery and radiotherapy J Neurosurg 101 Suppl3 381 9 15537193
66. R.J. Steenbakkers J.C. Duppen I. Fitton 2006 Reduction of observer variation using matched CT-PET for lung cancer delineation: a three-dimensional analysis Int J Radiat Oncol Biol Phys 64 435 48 16198064
67. J. Stroom H. Blaauwgeers A. van Baardwijk 2007 Feasibility of pathologycorrelated lung imaging for accurate target definition of lung tumors Int J Radiat Oncol Biol Phys 69 267 275 17707281
68. S. Sura C. Greco D. Gelblum 2008 (18)F-fluorodeoxyglucose positron emission tomography-based assessment of local failure patterns in non-small-cell lung cancer treated with definitive radiotherapy Int J Radiat Oncol Biol Phys 70 1397 402 18374225
69. K.S. Tralins J.G. Douglas K.J. Stelzer 2002 Volumetric analysis of 18F-FDG PET in glioblastoma multiforme: prognostic information and possible role in definition of target volumes in radiation dose escalation Nucl Med 43 1667 73
70. A. van Baardwijk G. Bosmans L. Boersma 2007 PET-CT-based auto-contouring in non-small-cell lung cancer correlates with pathology and reduces interobserver variability in the delineation of the primary tumor and involved nodal volumes Int J Radiat Oncol Biol Phys 68 771 8 17398018
71. A. van Baardwijk G. Bosmans L. Boersma 2008 Individualized radical radiotherapy of non-small-cell lung cancer based on normal tissue dose constraints: a feasibility study Int J Radiat Oncol Biol Phys 71 1394 401 18258380
72. A. van Der Wel S. Nijsten M. Hochstenbag 2005 Increased therapeutic ratio by 18FDG-PET-CT planning in patients with clinical CT stage N2/N3 M0 non-small cell lung cancer (NSCLC): a modelling study Int J Radiat Oncol Biol Phys 61 648 54
73. K. Van Laere S. Ceyssens F. Van Calenbergh 2005 Direct comparison of 18F-FDG and 11C-methionine PET in suspected recurrence of glioma: sensitivity, inter-observer variability and prognostic value Eur J Nucl Med Mol Imaging 32 39 51 1:CAS:528:DC%2BD2cXhtVOqsLjF 10.1007/s00259-004-1564-3 15309329 (Pubitemid 40142777)
74. J. van Loon D. De Ruysscher R. Wanders 2010 Selective nodal irradiation on basis of 18FDG-PET scans in limited disease small cell lung cancer: a phase II trial Int J Radiat Oncol Biol Phys 77 329 36 19782478
75. H. van Tinteren O.S. Hoekstra E.F. Smit 2002 Effectiveness of positron emission tomography in the preoperative assessment of patients with suspected non-small-cell lung cancer: the PLUS multicentre randomised trial Lancet 359 1388 93 10.1016/S0140-6736(02)08352-6 11978336 (Pubitemid 34442379)
76. H.L. van Westreenen M. Westerterp G.W. Sloof 2007 Limited additional value of positron emission tomography in staging oesophageal cancer Br J Surg 94 1515 20 10.1002/bjs.5708 17902092 (Pubitemid 350275631)
77. R.F. Vliegen R.G. Beets-Tan B. Vanhauten 2008 Can an FDG-PET/CT predict tumor clearance of the mesorectal fascia after preoperative chemoradiation of locally advanced rectal cancer? Strahlenther Onkol 184 457 64 10.1007/s00066-008-1858-7 19016024
78. O. Vrieze K. Haustermans W. De Wever 2004 Is there a role for FGD-PET in radiotherapy planning in esophageal carcinoma? Radiother Oncol 73 269 75 10.1016/j.radonc.2004.10.001 15588870 (Pubitemid 39601073)
79. D.C. Weber T. Zilli F. Buchegger 2008 [(18)]fluroroethyltyrosine-positron emission tomography-guided radiotherapy for high grade glioma Radiat Oncol 3 44 10.1186/1748-717X-3-44 19108742
80. J.D. Wright F. Dehdashti T.J. Herzog 2005 Preoperative lymph node staging of early-stage cervical carcinoma by [18F]-fluoro-2-deoxy-D-glucose-positron emission tomography Cancer 104 2484 91 10.1002/cncr.21527 16270319 (Pubitemid 41691572)
81. J. Yahalom 2005 Transformation in the use of radiation therapy of Hodgkin lymphoma: new concepts and indications lead to modern field design and are assisted by PET imaging and intensity modulated radiation therapy (IMRT) Eur J Haematol 66 90 7 10.1111/j.1600-0609.2005.00461.x
82. J.M. Zijlstra G. Lindauer-van der Werf O.S. Hoekstra 2006 18F-fluoro-deoxyglucose positron emission tomography for post-treatment evaluation of malignant lymphoma: a systematic review Haematologica 91 522 9 16585017